Phase 2 Study of Weekly Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: ECOG-ACRIN Cancer Research Group (E1898) Trial
Titel:
Phase 2 Study of Weekly Paclitaxel Plus Estramustine in Metastatic Hormone-Refractory Prostate Carcinoma: ECOG-ACRIN Cancer Research Group (E1898) Trial
Auteur:
Wong, Yu-Ning Manola, Judith Hudes, Gary R. Roth, Bruce J. Moul, Judd W. Barsevick, Andrea M. Scher, Richard M. Volk, Michael J. Vaughn, David J. Williams, Stephen D. Fisch, Michael J. Cella, David Carducci, Michael A. Wilding, George